Sandra Algarin-Perneth

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Tyrosine Kinase

Induced Pluripotent Stem Cells

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Algarin-Perneth, Riham Suleiman, Jithma P Abeykoon, Thorvardur R Halfdanarson, Harry E Fuentes-Bayne, Joanne E Yi, Tobias Peikert, Patrick W McGarrah
Deep and Repeated Response to Trastuzumab Deruxtecan in a Patient With Human Epidermal Growth Factor Receptor 2-Amplified Large-Cell Neuroendocrine Carcinoma With Brain Metastases: A Case Report. JCO precision oncology 7 (2023)